With shares of Oracle (NASDAQ:ORCL) trading around $34, is ORCL�an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
Oracle�is a provider of enterprise software and computer hardware products and services. The company’s software, hardware systems, and services businesses develop, manufacture, markets, host, and support database and middleware software, applications software, and hardware systems, with the latter consisting primarily of computer server and storage products. It is organized into three businesses: software, hardware systems, and services. Information technology products and services are seeing increasing demand due to the surge of companies in developing economies. As businesses continue to grow, look for Oracle to offer the support required that will send it to rising profits.
NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!T = Technicals on the Stock Chart are Mixed
Hot Stocks To Buy Right Now: adidas AG (ADDYY)
adidas AG designs, develops, produces, and markets through its own retail activities a range of athletic and sports lifestyle products. The Company operates in six segments: Wholesale, Retail, TaylorMade-adidas Golf, Rockport, Reebok-CCM Hockey and Other Centrally Managed Brands. adidas AG is the ultimate parent if the adidas Group. As of December 31, 2011, the Company had 169 subsidiaries worldwide. In June 2012, the Company announced that its TaylorMade-adidas Golf business segment completed the acquisition of Adams Golf, Inc.
The Wholesale segment consists of all business activities relating to the distribution of adidas and Reebok products to retail customers. The Retail segment consists of all business activities relating to the sales of adidas and Reebok products directly to consumers through own retail and own e-commerce platforms. adidas and Reebok branded products include footwear, apparel and hardware, such as bags and balls. TaylorMade-adidas Golf includes the three brands: TaylorMade, adidas Golf and Ashworth. TaylorMade designs, develops and assembles golf clubs, balls and accessories. adidas Golf branded products include footwear, apparel, and accessories. Ashworth designs and distributes men�� and women�� lifestyle sportswear. Rockport designs and markets leather footwear for men and women. Reebok-CCM Hockey designs, produces and markets hockey equipment, such as sticks and skates, as well as apparel mainly under the brand names, Reebok Hockey and CCM. The Other Centrally Managed Brands segment primarily includes the business activities of the Y-3 label, under which premium footwear and apparel are designed and distributed.
Advisors' Opinion:- [By Dan Carroll]
Europe's economic woes have been hitting German companies hard. Sporting-goods and clothing company Adidas (NASDAQOTH: ADDYY ) has grown its profit and margins recently, but the company's sales lagged in the first quarter, particularly in Western Europe, where revenue fell by 6%. This week, Adidas attempted to prop up its lagging Reebok division -- which the company purchased for $3.8 billion in 2006 -- by rebranding the segment with the symbol of its highly successful CrossFit program. There's no telling whether that's enough to turn around unprofitable Reebok and boost Adidas' margins further, but CrossFit has become a big success as a fitness program in Europe and the U.S.
- [By Jake Mann]
Enter Rich Froning
Rich Froning, the sport's equivalent of Michael Jordan, recently won a record fourth-straight CrossFit Games title. The victory came days after he signed a�long-term endorsement contract with�Adidas� (NASDAQOTH: ADDYY ) �subsidiary�Reebok.
10 Best Rising Stocks To Invest In 2014: Brown Shoe Company Inc. (BWS)
Brown Shoe Company, Inc., a footwear company, engages in the retail and wholesale of footwear. It operates through Famous Footwear, Wholesale Operations, and Specialty Retail segments. The company provides licensed, branded, and private-label casual, dress, and athletic footwear products to women, men, and children. It operates retail shoe stores under the Famous Footwear name that offer shoes of various brands, including Nike, Skechers, New Balance, Converse, adidas, DC, LifeStride, Reebok, Sperry, Asics, Puma, Dr. Scholl�s Shoes, Vans, BOC by Born, Sof Sole, Fergalicious, and Bearpaw. The company also operates shoe stores under the Naturalizer name, which provide women�s footwear, including casual, dress, sandals, and boots under the Naturalizer brand; operates retail stores under Dr. Scholl�s Shoes and Sam Edelman names; and sells its products through Internet retail that include Shoes.com, Famous.com, Naturalizer.com, Naturalizer.ca, and DrSchollsShoes.com, as well as ViaSpiga.com, LifeStride.com, and Ryka.com. As of February 2, 2013, it operated 1,277 retail shoe stores in the United States, Canada, China, and Guam. In addition, the company designs, sources, and markets footwear to retail stores, such as national chains, department stores, independent retailers, mass merchandisers, online retailers, and catalogs. Brown Shoe Company, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.
Advisors' Opinion:- [By Laura Brodbeck]
Friday
Earnings Expected From: �Buckle, Inc. (NYSE: BKE), Brown Shoe Company (NYSE: BWS) Economic Releases Expected: German CPI, Swiss PPIPosted-In: Crimea Reserve Bank of New ZealandEarnings News Guidance Previews Markets Trading Ideas Best of Benzinga
- [By Paul Ausick]
Big earnings movers: Tiffany & Co. (NYSE: TIF) reported better-than-expected earnings and revenues and raised its guidance slightly, but even posting a new 52-week high early could hold the stock from dropping about 1.3% today. Brown Shoe Co. Inc. (NYSE: BWS) also posted good earnings, but followed with slightly lower EPS guidance and the stock lost about 9%, trading around $21.60 in a 52-week range of $13.68 to $24.78. Another footwear maker, DSW Inc. (NYSE: DSW) put up good results and raised its guidance as well, sending shares up more than 9% to a new 52-week high of $88.73 in the mid-morning.
10 Best Rising Stocks To Invest In 2014: Resources Connection Inc.(RECN)
Resources Connection, Inc. provides professional services in the areas of finance, accounting, risk management and internal audit, corporate advisory, strategic communications and restructuring, information management, human capital, supply chain management, actuarial, and legal and regulatory services to support client-led projects and initiatives. It offers finance and accounting services, including financial analyses, budgeting and forecasting, audit preparation, public-entity reporting, tax-related projects, merger and acquisition due diligence, initial public offering assistance, and assistance in the preparation or restatement of financial statements; information management services, such as financial system/enterprise resource planning implementation, and post implementation optimization services; and corporate advisory, strategic communications, and restructuring services. The company also provides risk management and internal audit services comprising compliance r eviews, internal audit co-sourcing, and assistance services; supply chain management services, including strategic sourcing efforts, contract negotiations, and purchasing strategy services; and actuarial support services for pension and life insurance companies. In addition, it offers human capital services, such as change management, and compensation program design and implementation services; and legal and regulatory services comprising providing attorneys, paralegals, and contract managers to assist clients, such as law firms with project-based or peak period needs. Further, the company provides policyIQ, a Web-based content management product for documenting, managing, and communicating various types of business information, including policies and procedures, Sarbanes documentation, training documentation, and other business content. It operates in North America, Europe, and the Asia Pacific. The company was founded in 1996 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Ben Levisohn]
Resources Connection (RECN) has plunged 8.2% to $12.56 after it reported a profit of 9 cents a share, below forecasts for 11 cents.
- [By Jake L'Ecuyer]
Resources Connection (NASDAQ: RECN) shot up 7.38 percent to $15.29 after the company reported upbeat FQ2 earnings.
Rite Aid (NYSE: RAD) was also up, gaining 8.13 percent to $5.45 after the company reported a 2.9% gain in its December same-store sales.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Resources Connection (Nasdaq: RECN ) , whose recent revenue and earnings are plotted below.
10 Best Rising Stocks To Invest In 2014: Coronado Biosciences Inc (CNDO)
Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
TSO
TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.
CNDO-109
CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.
The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.
Advisors' Opinion:- [By Grace L. Williams]
Honorable mentions go out to Coronado Biosciences (CNDO), after its CEO Harlan Weisman and Jay Lobell, a longtime director, joined forces and bought 20,000 shares for $152,100; and to Anacor Pharmaceuticals (ANAC) after CFO Geoffrey Parker bought 33,000 shares for $224,300. InsiderScore noted that Parker�� purchase was his largest to date and called it a ��ompelling positive event.��/p>
- [By Roberto Pedone]
Coronado Biosciences (CNDO) is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock closed up 4.9% to $8.22 in Thursday's trading session.
Thursday's Range: $7.84-$8.29
52-Week Range: $4.00-$12.70
Thursday's Volume: 323,000
Three-Month Average Volume: 390,192From a technical perspective, CNDO spiked higher here right above its 200-day moving average of $7.63 with decent upside volume. This stock has been downtrending badly for the last three months, with shares falling from its high of $12.70 to its recent low of $7.32. During that move, shares of CNDO have been consistently making lower highs and lower lows, which is bearish technical price action. Shares of CNDO now look ready to reverse that trend and potentially trigger a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $8.56 to $8.94 with high volume.
Traders should now look for long-biased trades in CNDO as long as it's trending above its 200-day at $7.63 or above more support at $7.32 and then once it sustains a move or close above those breakout levels with volume that hits near or above 390,192 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to $10.35. Any high-volume move above those levels will then put its next major resistance level at $11 into range for shares of CNDO.
10 Best Rising Stocks To Invest In 2014: Spherix Inc (SPEX)
Spherix Incorporated (Spherix), incorporated on May 1, 1992, is a scientific research company. The Company is engaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the Company's biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business. The Company has created two wholly owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc. (Spherix Consulting), for its two operating segments. The Company's Health Sciences contracts are in the name of Spherix Consulting, and the Company's patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries. In September 2013, Spherix Incorporated closed on the acquisition of North South Holdings Inc.
Biospherics
The Company focuses its studies on treating high triglycerides and other dyslipidemias with a combination of D-tagatose and SPX-106, a licensed drug compound, which combination is referred to as SPX-106T. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides. Biospherics has also completed a global Phase III clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose, as a treatment for glycemic control in patients with Type 2 diabetes.
Health Sciences
The Company's Health Sciences business provides technical and regulatory consulting services to biotechnology and pharmaceutical companies, as well as providing technical suppo! rt for its research and development activities. During the year ended December 31, 2011, Health Sciences provided services to 20 companies. The projects range from safety analyses of food ingredients to safety analyses of pharmaceutical manufacturing and dispensing equipment. Health Sciences is also monitoring and directing the clinical trials for Biospherics.
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Spherix Inc.(SPEX) on Thursday said that it is suing Cisco Inc.(CSCO) (CSCO), a leging that $43 billion in Cisco sales infringed on Spherix patents. Spherix–which described itself as an “intellectual property development company committed to the fostering and monetization of intellectual property”��aid Cisco infringes on 11 patents it acquired in December. Spherix shares rose 4.9% to $4.70 premarket.
10 Best Rising Stocks To Invest In 2014: Marcolin SpA (MCL)
Marcolin SpA is an Italy-based eyewear manufacturer. It is a manufacturer of glasses and sunglasses for such brands as Tom Ford, Roberto Cavalli and Just Cavalli, Diesel, Montblanc, Tod's and Hogan, Balenciaga, Swarovski, Timberland, DSquared2 and Kenneth Cole. Advisors' Opinion:- [By John McCamant]
Our top stock selection for 2014 has received three Breakthrough Therapy Designations (BTD) by the FDA, and subsequent approval, in November, for Imbruvica, a very safe pill that has shown unprecedented efficacy to treat mantle cell lymphoma (MCL), suggests John McCamant, editor of The Medical Technology Stock Letter.
10 Best Rising Stocks To Invest In 2014: Chindex International Inc.(CHDX)
Chindex International, Inc. engages in the provision of healthcare services; and sale of medical equipment, instrumentation, and products. The company operates in two segments, Healthcare Services and Medical Products. The Healthcare Services segment owns and operates the United Family Healthcare network of private hospitals and clinics in the Beijing, Shanghai, and Guangzhou markets. This segment also operates a managed clinic in the city of Wuxi, south of Shanghai. It offers a range of family healthcare services, including 24/7 emergency rooms, intensive care units, and neonatal intensive care units, operating rooms, clinical laboratory, radiology, and blood banking services for men, women, and children. The Medical Products segment markets, distributes, and sells medical capital equipment, instrumentation, and other medical products for use in hospitals in China and Hong Kong. It offers diagnostic color ultrasound imaging devices, robotic surgical systems and instrument ation, mammography and breast biopsy devices, and lasers for cosmetic surgery. This segment sells its products through its direct sales force. The company was founded in 1981 and is based in Bethesda, Maryland.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading the sector was strength from Forest Laboratories (NYSE: FRX) and Chindex International (NASDAQ: CHDX) on acquisition news. In trading on Tuesday, non-cyclical consumer goods & services shares were relative laggards, down on the day by 0.2%.
No comments:
Post a Comment